CF
CNA Financial Portfolio holdings
AUM
$195M
This Quarter Return
-6.57%
1 Year Return
+20.43%
3 Year Return
+79.36%
5 Year Return
+144.91%
10 Year Return
+226.32%
AUM
$322M
AUM Growth
+$322M
(-16%)
Cap. Flow
-$24.3M
Cap. Flow
% of AUM
-7.55%
Top 10 Holdings %
Top 10 Hldgs %
31.34%
Holding
203
New
11
Increased
51
Reduced
71
Closed
16
Top Buys
| 1 |
Cheniere Energy
LNG
|
$6.93M |
| 2 |
Morgan Stanley
MS
|
$6.12M |
| 3 |
Hanesbrands
HBI
|
$4.47M |
| 4 |
Meta Platforms (Facebook)
META
|
$4M |
| 5 |
General Motors
GM
|
$3.94M |
Top Sells
| 1 |
Pfizer
PFE
|
$8.86M |
| 2 |
CoStar Group
CSGP
|
$7.11M |
| 3 |
CME Group
CME
|
$6.17M |
| 4 |
Jacobs Solutions
J
|
$5.57M |
| 5 |
JPMorgan Chase
JPM
|
$4.75M |
Sector Composition
| 1 | Technology | 22.54% |
| 2 | Healthcare | 19.56% |
| 3 | Consumer Discretionary | 14.54% |
| 4 | Industrials | 8.94% |
| 5 | Financials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
176
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $252K | 0.08% |
9,403
+320
| +4% | +$8.58K |
|
177
Instil Bio
TIL
$182M
| $244K | 0.08% |
22,688
| – | – |
|
178
ADC Therapeutics
ADCT
$345M
| $228K | 0.07% |
15,515
+270
| +2% | +$3.97K |
|
179
Recursion Pharmaceuticals
RXRX
$2.04B
| $205K | 0.06% |
28,672
+2,890
| +11% | +$20.7K |
|
180
Jamf
JAMF
$1.24B
| $203K | 0.06% |
5,837
| – | – |
|
181
Praxis Precision Medicines
PRAX
$958M
| $191K | 0.06% |
18,741
+510
| +3% | +$5.2K |
|
182
Sight Sciences
SGHT
$213M
| $189K | 0.06% |
16,383
+2,356
| +17% | +$27.2K |
|
183
Erasca
ERAS
$445M
| $147K | 0.05% |
17,077
| – | – |
|
184
Soho House & Co
SHCO
$1.72B
| $114K | 0.04% |
14,684
-13,603
| -48% | -$106K |
|
|
PAYA
185
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $67K | 0.02% |
11,434
-49,020
| -81% | -$287K |
|
186
Annexon
ANNX
$226M
| $64K | 0.02% |
23,423
+3,713
| +19% | +$10.1K |
|
187
XWELL
XWEL
$6.33M
| $35K | 0.01% |
31,369
| – | – |
|
188
Amplitude
AMPL
$1.51B
| – | – |
-11,213
| Closed | -$594K |
|
189
BioXcel Therapeutics
BTAI
$59M
| – | – |
-14,359
| Closed | -$292K |
|
190
Comcast
CMCSA
$125B
| – | – |
-80,000
| Closed | -$4.03M |
|
|
191
CME Group
CME
$96B
| – | – |
-27,000
| Closed | -$6.17M |
|
|
192
CoStar Group
CSGP
$37.9B
| – | – |
-90,000
| Closed | -$7.11M |
|
193
CryoPort
CYRX
$444M
| – | – |
-4,313
| Closed | -$255K |
|
194
Guardant Health
GH
$8.41B
| – | – |
-2,928
| Closed | -$293K |
|
195
Hydrofarm Holdings
HYFM
$21.6M
| – | – |
-17,658
| Closed | -$500K |
|
|
196
Jacobs Solutions
J
$17.5B
| – | – |
-40,000
| Closed | -$5.57M |
|
|
197
JPMorgan Chase
JPM
$829B
| – | – |
-30,000
| Closed | -$4.75M |
|
|
198
Pfizer
PFE
$141B
| – | – |
-150,000
| Closed | -$8.86M |
|
199
Riskified
RSKD
$748M
| – | – |
-23,216
| Closed | -$182K |
|
200
Twist Bioscience
TWST
$1.63B
| – | – |
-3,879
| Closed | -$300K |
|